Alzamend Neuro Inc [ALZN] stock prices are up 32.15% to $0.89 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The ALZN shares have gain 26.27% over the last week, with a monthly amount drifted -17.14%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Alzamend Neuro Inc [NASDAQ: ALZN] stock has seen the most recent analyst activity on October 01, 2021, when Ascendiant Capital Markets initiated its Buy rating and assigned the stock a price target of $8.
The stock price of Alzamend Neuro Inc [ALZN] has been fluctuating between $0.64 and $15.06 over the past year. Alzamend Neuro Inc [NASDAQ: ALZN] shares were valued at $0.89 at the most recent close of the market.
Analyzing the ALZN fundamentals
Gross Profit Margin for this corporation currently stands at 0.67% with Operating Profit Margin at -55.29%, Pretax Profit Margin comes in at -55.54%, and Net Profit Margin reading is -55.54%. To continue investigating profitability, this company’s Return on Assets is posted at -1.01, Equity is -4.98 and Total Capital is -1.22.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.7722 points at the first support level, and at 0.6495 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.9575, and for the 2nd resistance point, it is at 1.0201.
Ratios To Look Out For
It’s worth pointing out that Alzamend Neuro Inc [NASDAQ:ALZN]’s Current Ratio is 5.44. Also, the Quick Ratio is 5.44, while the Cash Ratio stands at 4.63.
Transactions by insiders
Recent insider trading involved AULT MILTON C III, Director, that happened on Mar 12 ’25 when 100.0 shares were purchased. Director, AULT MILTON C III completed a deal on Aug 06 ’24 to buy 75.0 shares. Meanwhile, Director AULT MILTON C III bought 25.0 shares on Jul 31 ’24.
